ITGAM and Hepatic fibrosis: A reduction in hepatic expression of CCR2, eight weeks after a CD11b CD14+ monocyte infusion, may indicate a reduction of Ly6Chi monocytes of pro-inflammatory profile in liver of the animals submitted to cell therapy, favoring the liver fibrosis improvement.